MEMPHIS TN 381632116
Tel: (901) 448-5240


  • Other, Indiana University School of Medicine, Diabetes Endocrinology and Metabolism
  • Other, Indiana University School of Medicine, Internal Medicine
  • None, University of Bochum, Epidemiology
  • M.D., University of Heidelberg School of Medicine, Medicine

Clinical Care Specialty/Interest

 Diabetes and general endocrinology in hospital and out-patient setting

Management of chronic diseases

Behavioral determinants of successful glucose and risk factor control

Research Interest/Specialty

 Diabetes, Endocrinology and Metabolism

Insulin resistance and vacular reactivity

Effect of macronutrients on markers of vascular function

Management of chronic diseases

Drug development


  1. Shankar, SS, Shankar, RR, Mixson, LA, Miller, DL, Chung, C, Cilissen, C, Beals, CR, Stoch, SA, Steinberg, HO, Kelley, DE. Linearity of β-cell response across the metabolic spectrum and to pharmacology: insights from a graded glucose infusion-based investigation series. Am J Physiol Endocrinol Metab, 310 (11), E865-73, 2016.
  2. Steinberg, HO. Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes. Postgrad Med, 128 (4), 398-408, 2016.
  3. ,. Prospective Association of GLUL rs10911021 With Cardiovascular Morbidity and Mortality Among Individuals With Type 2 Diabetes: The Look AHEAD Study. Diabetes, 65 (1), 297-302, 2016.
  4. Shankar, SS, Shankar, RR, Railkar, RA, Beals, CR, Steinberg, HO, Kelley, DE. Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population. Curr Ther Res Clin Exp, 77, 83-9, 2015.
  5. Steinberg, H, Jacovino, C, Kitabchi, AE. Look inside Look AHEAD: why the glass is more than half-full. Curr Diab Rep, 14 (7), 500, 2014.
  6. Steinberg, H, Anderson, MS, Musliner, T, Hanson, ME, Engel, SS. Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin. Vasc Health Risk Manag, 9, 273-82, 2013.
  7. Mather, KJ, Steinberg, HO, Baron, AD. Insulin resistance in the vasculature. J Clin Invest, 123 (3), 1003-4, 2013.
  8. Fonseca, V, Staels, B, Morgan, JD, Shentu, Y, Golm, GT, Johnson-Levonas, AO, Kaufman, KD, Goldstein, BJ, Steinberg, H. Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes. J Diabetes Complications, 27 (2), 177-83, 2012.
  9. Barzilai, N, Guo, H, Mahoney, EM, Caporossi, S, Golm, GT, Langdon, RB, Williams-Herman, D, Kaufman, KD, Amatruda, JM, Goldstein, BJ, Steinberg, H. Efficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin, 27 (5), 1049-58, 2011.
  10. Shankar, SS, Steinberg, HO. Weight loss and vascular function: the good and the unknown. Hypertension, 52 (1), 57-8, 2008.
  11. Bax, JJ, Young, LH, Frye, RL, Bonow, RO, Steinberg, HO, Barrett, EJ, ,. Screening for coronary artery disease in patients with diabetes. Diabetes Care, 30 (10), 2729-36, 2007.
  12. Hardy, TA, Meyers, AL, Yu, J, Shankar, SS, Steinberg, HO, Porksen, NK. Acute insulin response and beta-cell compensation in normal subjects treated with olanzapine or risperidone for 2 weeks. Diabetes Care, 30 (1), 157-8, 2007.
  13. Shankar, SS, Considine, RV, Gorski, JC, Steinberg, HO. Insulin sensitivity is preserved despite disrupted endothelial function. Am J Physiol Endocrinol Metab, 291 (4), E691-6, 2006.
  14. Bell, LN, Ward, JL, Degawa-Yamauchi, M, Bovenkerk, JE, Jones, R, Cacucci, BM, Gupta, CE, Sheridan, C, Sheridan, K, Shankar, SS, Steinberg, HO, March, KL, Considine, RV. Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab, 291 (4), E843-8, 2006.
  15. Shankar, SS, Dubé, MP, Gorski, JC, Klaunig, JE, Steinberg, HO. Indinavir impairs endothelial function in healthy HIV-negative men. Am Heart J, 150 (5), 933, 2005.
  16. Shankar, SS, Steinberg, HO. FFAs: do they play a role in vascular disease in the insulin resistance syndrome. Curr Diab Rep, 5 (1), 30-5, 2005.
  17. Shankar, SS, Steinberg, HO. Obesity and endothelial dysfunction. Semin Vasc Med, 5 (1), 56-64, 2005.
  18. Shankar, SS, Mirzamohammadi, B, Walsh, JP, Steinberg, HO. L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann N Y Acad Sci, 1033, 189-97, 2004.
  19. Mather, KJ, Lteif, A, Steinberg, HO, Baron, AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes, 53 (8), 2060-6, 2004.